|
|
Exchange: |
N/A |
Security
Type: |
Common |
Shares
Out: |
173,970,000 |
Market
Cap: |
4.87(B) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$14 - $43.89 |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile BridegeBio Pharma identifies and improves medicines to treat patients who suffer from Mendelian diseases, which are diseases that arise from defects in a single gene, and cancers with clear genetic drivers. Co.'s pipeline are: Acoramidis/AG10/BBP-265, a small molecule transthyretin (TTR) stabilizer for the treatment of TTR amyloidosis; Infigratinib/BBP-831, an oral FGFR1-3 selective tyrosine kinase inhibitor for the treatment of achondroplasia; BBP-631, a preclinical adeno-associated virus gene transfer for the treatment of congenital adrenal hyperplasia; and Encaleret, a small molecule antagonist of the calcium sensing receptor for the treatment of Autosomal Dominant Hypocalcemia Type 1.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
113,245 |
1,769,632 |
2,886,602 |
Total Sell Value |
$0 |
$4,697,014 |
$61,715,300 |
$73,415,196 |
Total People Sold |
0 |
3 |
6 |
6 |
Total Sell Transactions |
0 |
6 |
14 |
29 |
End Date |
2024-03-03 |
2023-12-01 |
2023-06-02 |
2022-06-02 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Stephenson Brian C |
Secretary, Treasurer & CFO |
|
2024-05-16 |
4 |
D |
$31.04 |
$432,791 |
D/D |
(13,943) |
76,472 |
|
- |
|
Stephenson Brian C |
Secretary, Treasurer & CFO |
|
2024-05-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
27,507 |
90,415 |
|
- |
|
Kumar Neil |
CEO and President |
|
2024-05-16 |
4 |
D |
$31.04 |
$954,418 |
D/D |
(30,748) |
4,897,443 |
|
- |
|
Kumar Neil |
CEO and President |
|
2024-05-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
60,667 |
4,928,191 |
|
- |
|
Scott Randal W |
|
|
2024-03-01 |
4 |
AS |
$34.00 |
$85,000 |
I/I |
(2,500) |
6,500 |
|
-21% |
|
Homcy Charles J |
|
|
2024-02-16 |
4 |
D |
$37.21 |
$56,150 |
D/D |
(1,509) |
1,230,085 |
|
- |
|
Homcy Charles J |
|
|
2024-02-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,760 |
1,231,594 |
|
- |
|
Stephenson Brian C |
Secretary, Treasurer & CFO |
|
2024-02-16 |
4 |
D |
$37.21 |
$703,976 |
D/D |
(18,919) |
62,908 |
|
- |
|
Stephenson Brian C |
Secretary, Treasurer & CFO |
|
2024-02-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
44,996 |
81,827 |
|
- |
|
Kumar Neil |
CEO and President |
|
2024-02-16 |
4 |
D |
$37.21 |
$1,783,178 |
D/D |
(47,922) |
4,867,524 |
|
- |
|
Kumar Neil |
CEO and President |
|
2024-02-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
102,249 |
4,915,446 |
|
- |
|
Valantine Hannah |
|
|
2024-02-15 |
4 |
AS |
$37.75 |
$110,041 |
D/D |
(2,915) |
1,764 |
|
-29% |
|
Valantine Hannah |
|
|
2024-02-15 |
4 |
OE |
$8.45 |
$24,632 |
D/D |
2,915 |
4,679 |
|
- |
|
Valantine Hannah |
|
|
2024-01-16 |
4 |
AS |
$37.97 |
$110,683 |
D/D |
(2,915) |
1,764 |
|
-26% |
|
Valantine Hannah |
|
|
2024-01-16 |
4 |
OE |
$8.45 |
$24,632 |
D/D |
2,915 |
4,679 |
|
- |
|
Mccormick Frank |
Director |
|
2023-12-26 |
4 |
AS |
$42.06 |
$4,206,000 |
I/I |
(100,000) |
627,689 |
|
-34% |
|
Scott Randal W |
Director |
|
2023-12-18 |
4 |
AS |
$40.00 |
$80,000 |
I/I |
(2,000) |
9,000 |
|
-33% |
|
Valantine Hannah |
Director |
|
2023-12-15 |
4 |
AS |
$36.12 |
$105,290 |
D/D |
(2,915) |
1,764 |
|
-35% |
|
Valantine Hannah |
Director |
|
2023-12-15 |
4 |
OE |
$8.45 |
$24,632 |
D/D |
2,915 |
4,679 |
|
- |
|
Scott Randal W |
Director |
|
2023-12-01 |
4 |
AS |
$28.50 |
$73,500 |
I/I |
(2,500) |
11,000 |
|
-13% |
|
Stephenson Brian C |
Secretary, Treasurer & CFO |
|
2023-11-17 |
4 |
AS |
$29.10 |
$660,059 |
D/D |
(22,685) |
36,710 |
|
3% |
|
Kumar Neil |
CEO and President |
|
2023-11-17 |
4 |
AS |
$29.10 |
$1,500,038 |
D/D |
(51,552) |
4,813,197 |
|
3% |
|
Stephenson Brian C |
Secretary, Treasurer & CFO |
|
2023-11-16 |
4 |
D |
$28.86 |
$643,895 |
D/D |
(22,311) |
59,395 |
|
- |
|
Stephenson Brian C |
Secretary, Treasurer & CFO |
|
2023-11-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
44,996 |
81,706 |
|
- |
|
Homcy Charles J |
Director |
|
2023-11-16 |
4 |
D |
$28.86 |
$37,547 |
D/D |
(1,301) |
1,226,996 |
|
- |
|
292 Records found
|
|
Page 1 of 12 |
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Acquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|